EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development

Yasushi Rino, Kazuo Tarao

ISRN Oncology · 2011

DOI: 10.5402/2011/390676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Oncology, 2011. Verfasst von Yasushi Rino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nowadays, patients with chronic hepatitis C in all countries are generally treated with interferon (IFN), and more than 50% of patients become HCV-RNA negative following PEG-IFN plus ribavirin therapy, but unfortunately, the IFN therapy is not effective in about 70% of patients with HCV-associated LC. In Japan, HCC actually develops in about 7% of those patients every year. A strategy for preventing HCC development other than IFN therapy is, therefore, urgently needed for those patients. We reported that the recurrence rate and the development of HCC was more rapid in the high serum ALT level (>80 IU) patients with HCV-associated LC. Sho-saiko-to, Juzen-taiho-to, and stronger-neo minophagen C are herbal medicines used in Japan to treat chronic viral liver diseases, and they work by reducing inflammatory processes and controlling ALT levels. Aggressive reduction therapy for ALT levels in HCV-LC patients could significantly prevent HCC development.

Autor:innen und Institutionen

  • Department of Surgery, Yokohama City University, 3-9, Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

Zitieren

APA

Rino, Y., & Tarao, K. (2011). Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development. ISRN Oncology. https://doi.org/10.5402/2011/390676

Vancouver

Rino Y, Tarao K. Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development. ISRN Oncology. 2011. doi:10.5402/2011/390676

BibTeX
@article{Rino2011,
  author = {Rino, Yasushi and Tarao, Kazuo},
  title = {Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development},
  journal = {ISRN Oncology},
  year = {2011},
  doi = {10.5402/2011/390676}
}
Kostenlos starten →